Synthetic cell built from scratch grows and divides
MIT and Harvard researchers created a fully synthetic cell that doubled its size and performed binary fission in vitro, marking a concrete milestone for bottom‑up synthetic biology.
Researchers at MIT and Harvard assembled a synthetic cell with a 1.2‑million‑base‑pair genome derived from Mycoplasma mycoides, encoding 473 essential genes and inserted via a cell‑free transcription‑translation system. The cell doubled its volume and performed binary fission inside a lipid‑vesicle reactor on July 1 2026 [Quanta Magazine][Nature].
Growth was driven by a supplied cocktail of nucleotides, amino acids, and ATP; division was triggered by programmed oscillatory expression of the FtsZ protein. The synthetic cell completed a full replication cycle in 3.8 hours, matching the division time of its natural counterpart. Electron microscopy captured a constriction ring at the midpoint, and fluorescence‑based lineage tracking confirmed that each daughter inherited a complete copy of the synthetic genome. Continuous perfusion of nutrients was required, showing dependence on an external supply chain for energy and building blocks [Nature].
The experiment proves autonomous replication in a bottom‑up construct—a capability previously limited to separate growth or metabolic functions [Nature]. Because the genome is synthetic, engineers can insert or delete pathways with single‑gene precision, creating a programmable chassis for biomanufacturing pharmaceuticals or specialty chemicals [Quanta Magazine]. The ability to program a self‑replicating cell also raises biosecurity concerns; experts call for updated oversight mechanisms in synthetic‑biology governance [Nature Biotechnology].
Editor’s take: The cell’s reliance on a continuously refreshed nutrient feed means it is not yet an independent organism. Until autonomous metabolism and robust stress tolerance are engineered, the system remains a laboratory proof‑of‑concept rather than a production platform. Scaling from microliter chambers to bioreactors will be the decisive test.
Reader poll
Which synthetic‑biology platform will power the next wave of biotech?
- Bottom‑up minimal cells
- Top‑down genome‑reduced microbes
- Cell‑free synthetic factories
Subscribe to the broadcast.
Daily digest of the day's most important tech news. No fluff. Engineering signal only.
// delivered via substack · double-opt-in confirmation